Breast cancer
Results
Phase 3
This study looked at tissue samples to compare the effects of drugs called anastrozole (Arimidex) and letrozole (Femara) on breast cancer cells.
Recruitment start: 1 June 2002
Recruitment end: 17 December 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor JM Dixon
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 05 Dec 2013
CRUK internal database number: 4373